Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial (vol 8, pg 834, 2020)

被引：0
|
作者：
Feig, D. S.
Donovan, L. E.
Zinman, B.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [31] Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
    Davalos, Antoni
    Alvarez-Sabin, Jose
    Castillo, Jose
    Diez-Tejedor, Exuperio
    Ferro, Jose
    Martinez-Vila, Eduardo
    Serena, Joaquin
    Segura, Tomas
    Cruz, Vitor T.
    Masjuan, Jaime
    Cobo, Erik
    Secades, Julio J.
    LANCET, 2012, 380 (9839): : 349 - 357
  • [32] Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial (vol 390, 2347, 2017)
    Feig, D. S.
    Donovan, L. E.
    Corcoy, R.
    LANCET, 2017, 390 (10110): : 2346 - 2346
  • [33] Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
    Gerstein, Hertzel C.
    Colhoun, Helen M.
    Dagenais, Gilles R.
    Diaz, Rafael
    Lakshmanan, Mark
    Pais, Prem
    Probstfield, Jeffrey
    Botros, Fady T.
    Riddle, Matthew C.
    Ryden, Lars
    Xavier, Denis
    Atisso, Charles Messan
    Dyal, Leanne
    Hall, Stephanie
    Rao-Melacini, Purnima
    Wong, Gloria
    Avezum, Alvaro
    Basile, Jan
    Chung, Namsik
    Conget, Ignacio
    Cushman, William C.
    Franek, Edward
    Hancu, Nicolae
    Hanefeld, Markolf
    Holt, Shaun
    Jansky, Petr
    Keltai, Matyas
    Lanas, Fernando
    Leiter, Lawrence A.
    Lopez-Jaramillo, Patricio
    Cardona Munoz, Ernesto German
    Pirags, Valdis
    Pogosova, Nana
    Raubenheimer, J.
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    LANCET, 2019, 394 (10193): : 131 - 138
  • [34] Dulaglutide in youth with type 2 diabetes: results of the AWARD-PEDS randomised, placebo-controlled trial
    Arslanian, S.
    Hannon, T.
    Zeitler, P.
    Chao, L.
    Boucher-Berry, C.
    Barrientos-Perez, M.
    Bismuth, E.
    Dib, S.
    Cho, J.
    Cox, D.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S58 - S58
  • [35] The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial
    McGavock, Jonathan
    Szczepaniak, Lidia S.
    Ayerss, Colby R.
    Abdullah, Shuaib M.
    See, Raphael
    Gore, M. Odette
    Drazner, Mark H.
    de Lemos, James A.
    McGuire, Darren K.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 131 - 137
  • [36] The effects of metformin on weight loss in women with gestational diabetes: a pilot randomized, placebo-controlled trial
    Refuerzo, Jerrie S.
    Viteri, Oscar A.
    Hutchinson, Maria
    Pedroza, Claudia
    Blackwell, Sean C.
    Tyson, Jon E.
    Ramin, Susan M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (03) : 389.e1 - 389.e9
  • [37] Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial
    Joseph Proietto
    Jaret Malloy
    Dongliang Zhuang
    Mark Arya
    Neale D. Cohen
    Ferdinandus J. de Looze
    Christopher Gilfillan
    Paul Griffin
    Stephen Hall
    Thomas Nathow
    Geoffrey S. Oldfield
    David N. O’Neal
    Adam Roberts
    Bronwyn G. A. Stuckey
    Dennis Yue
    Kristin Taylor
    Dennis Kim
    Diabetologia, 2018, 61 : 1918 - 1922
  • [38] Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial
    Proietto, Joseph
    Malloy, Jaret
    Zhuang, Dongliang
    Arya, Mark
    Cohen, Neale D.
    de Looze, Ferdinandus J.
    Gilfillan, Christopher
    Griffin, Paul
    Hall, Stephen
    Nathow, Thomas
    Oldfield, Geoffrey S.
    O'Neal, David N.
    Roberts, Adam
    Stuckey, Bronwyn G. A.
    Yue, Dennis
    Taylor, Kristin
    Kim, Dennis
    DIABETOLOGIA, 2018, 61 (09) : 1918 - 1922
  • [39] Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
    Imai, E.
    Chan, J. C. N.
    Ito, S.
    Yamasaki, T.
    Kobayashi, F.
    Haneda, M.
    Makino, H.
    DIABETOLOGIA, 2011, 54 (12) : 2978 - 2986
  • [40] Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
    E. Imai
    J. C. N. Chan
    S. Ito
    T. Yamasaki
    F. Kobayashi
    M. Haneda
    H. Makino
    Diabetologia, 2011, 54 : 2978 - 2986
12345